Filing Flows

Filing Flows › Rigel Pharmaceuticals (RIGL) › Who owns the stock

Who owns Rigel Pharmaceuticals (RIGL) stock

144 funds reported Rigel Pharmaceuticals (RIGL) shares in their latest 13F filings, worth $673M in all. The largest holder is BlackRock ($75.9M). Last quarter 74 funds added to their stakes and 70 cut them.

Largest holders of RIGL (13F)Largest holders of RIGL (13F)BlackRock$75.9MSoleus Capital Management, L.P.$72.1MArmistice Capital, LLC$65.4MVanguard Group$44.5MState Street$40.7MVanguard Capital Management LLC$30.7MAmerican Century Companies$29.0MAssenagon Asset Management S.A.$25.8MAcadian Asset Management LLC$23.1MD. E. Shaw$21.2M

Largest holders (13F)

FundSharesValueChangeQuarter
BlackRock1,939,818$75.9Mincrease2026-06-30
Soleus Capital Management, L.P.1,843,504$72.1Mincrease2026-06-30
Armistice Capital, LLC1,672,000$65.4Mincrease2026-06-30
Vanguard Group1,038,408$44.5Mdecrease2025-12-31
State Street1,039,994$40.7Mdecrease2026-06-30
Vanguard Capital Management LLC785,107$30.7Mincrease2026-06-30
American Century Companies741,718$29.0Mincrease2026-06-30
Assenagon Asset Management S.A.535,685$25.8Mnew2026-09-30
Acadian Asset Management LLC591,686$23.1Mdecrease2026-06-30
D. E. Shaw542,539$21.2Mincrease2026-06-30
Geode Capital Management, LLC483,175$18.9Mincrease2026-06-30
Marshall Wace, LLP367,393$14.4Mdecrease2026-06-30
Vanguard Portfolio Management LLC233,728$9.1Mincrease2026-06-30
Dimensional Fund Advisors LP227,951$8.9Mdecrease2026-06-30
Goldman Sachs Group226,780$8.9Mdecrease2026-06-30

Rigel Pharmaceuticals' latest quarter

Rigel Pharmaceuticals, Q3 2026: revenue $80.9M (+16% year over year), operating margin 21.1%, net earnings $13.2M, operating cash flow $34.6M. The chart follows the revenue to costs, profit and cash.

Questions

Who owns the most RIGL stock?

By the latest 13F filings: BlackRock ($75.9M); Soleus Capital Management, L.P. ($72.1M); Armistice Capital, LLC ($65.4M); Vanguard Group ($44.5M); State Street ($40.7M).

What is the short interest in RIGL?

2,732,739 shares were sold short at the 2026-10-15 settlement, -4.3% of the float.

Open the interactive view →

Updated Nov 8, 2026. Read automatically from SEC filings and public data; errors are possible. Not investment advice.